Infertility and IVF applications


Applications of infertility and IVF:

Rooyagen "PRP" kit after success in several indications for use such as: musculoskeletal, chronic wounds, skin rejuvenation and hair loss treatment, each of which has a different platelet concentration and activity. with the latest results Research, the Rooyagen R&D team has successfully developed a clinical kit for infertility caused by RIF and thin endometrium has found clinical indications. Fortunately, it is used in most centers of the country.

The most important challenge facing PRP is the separation of enriched platelets in terms of concentration fold, efficiency, activity of platelet growth factors, type and number of lymphocytes for different uses. Confirmed by the clinical laboratory (at least for 1% of clients). Also, since 2016, the clinical use of PRP with code 302365 (with coefficient k20) has been mentioned in the tariff book of the Ministry of Health of the Islamic Republic of Iran.


Side effects:

There is no risk by following the instructions of Rooyagen Kit and contraindications. Due to the sensitivity of uterine tissue and the irreversibility of its side effects if not properly optimized and the use of inappropriate kits, it should be noted that knowing the specific requirements and sensitivities of IVF indication and infertility with other indications from Musculoskeletal sentences, beauty, chronic wounds, etc. are different and in some cases contradictory. With FERTILIZE LYMPHO PRP product based on evidence-based studies (EBM), Rooyagen has been able to offer different products approved by scientific journals and relevant experts.

Enrichment factor and intervals of use (injection):

For optimal PRP, platelet concentrations should be optimized, and for RIF and thin endometrium indications, this dose should be between 4 and 5 times the baseline value. The effectiveness of this range has been demonstrated in a trial using a Rooyagen kit. In the case of thin endometrium, it is twice at 48 hours, and in the case of RIF, once, 24 to 48 hours before embryo transfer.


Performance indicators and expected results:

The expected results in the mentioned infertility indicators have been shown in valid studies. Recently, lymphocyte-enriched platelets in the field of thin endometrium and RIF in IVF ward of Taleghani Hospital, Shahid Beheshti University of Medical Sciences It has been used with great success in the field of 100% curable thin endometrium. The success rate in RIF in the first phase of the study was about 80% and in the continuation of the study in women under 40 years of age, with a suitable endometrium and a fetus of good quality without genetic and immunological problems, about 66%.


About us

  • Rooyagen brand (ROOYA GEN) owned by Aria Mabna TashKhis -Knowledge based -Company, was born in 2010. Rooyagen, while entering the field of medical device production, became the first platelet processing and concentrating (PRP) kit in Iran after obtaining the relevant licenses. The first product in the Rooyagen PRP kit was for musculoskeletal use.

  • From the beginning of 2013, Rooyagen was able to launch another product in the field of skin rejuvenation and hair loss treatment. One of the honors of the Rooyagen brand is active participation in scientific and academic forums. The products of this brand have been cited in several (more than 50) scientific articles and have received over 1000 referral citation from scientific studies.

  • Following the path of research and development in 2016, another product of Rooyagen was produced for the treatment of chronic wounds. This kit was produced as a platelet gel with high durability and Sustain release technology and brought brilliant results. Accompaniment of professors of Tehran University of Medical Sciences - Shariati Hospital was published and is now available in clinics for the treatment of diabetic wounds and other chronic wounds

  • Simultaneously with achieving promising results for the treatment of infertility worldwide, Rooyagen product for infertility uses such as recurrent miscarriage and thin endometrium, has successfully passed its research and development stages and with the cooperation of professors of Taleghani Hospital- Beheshti University of Medical Sciences It has been clinically proven and its results have been published in authoritative ISI articles. Fortunately, today most infertility centers in the country are using this product to help infertile couples. we are proud continuing this path with your support and enthusiasm for new services to patients in need ...

  • Be Part
    Of Our

Unit 1, No.11,setayesh, satarkhanSt., Tehran.

+98 66512800